The number of registered NIH-funded trials listed on ClinicalTrials.gov decreased between 2006 through 2014; however, the number of industry-funded trials increased substantially.
A small study showed the safety of using gene therapy in the salivary gland to repair damage caused by radiation for head and neck cancer.
Compared with prostatectomy, surveillance will likely reduce prostate cancer-specific survival only slightly and greatly enhance quality of life.
A new optical imaging technology could give doctors new ways to both identify breast cancer and to monitor the responses of individual patients to initial treatments of the disease. Tufts Medical Center in Boston is now undertaking a five-year clinical study of the procedure through a $3.5 million grant from the National Institutes of Health.
